Browsing by Subject "Omalizumab"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Treatment of estrogen-induced dermatitis with omalizumab
    (Elsevier, 2019-05-25) Ocana, Jesus A.; Bell, Maria C.; Heskett, Jordan B.; Baker, William H.; Mousdicas, Nico; Turner, Matthew J.; Dermatology, IU School of Medicine
    In 1945, Drs Bernhard Zondek and Yehuda Bromberg demonstrated intradermal treatment with estrone and estradiol benzoate induced urticarial lesions in some patients.1 Fifty years later, Shelley et al,2 who introduced the concept of progesterone dermatitis several decades prior, defined estrogen dermatitis based on studies of 7 women with premenstrual flares of skin eruptions including papulovesicular, urticarial, or eczematous lesions or generalized pruritus. Previously described therapies for estrogen dermatitis include estrogen desensitization, tamoxifen, leuprolide, and oophorectomy.3 Here we report a case of estrogen-induced dermatitis successfully treated with omalizumab.